Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Cyclosporin A helps damaged hair follicles regrow hair quickly.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

The guide suggests using keratin fibers and wigs to help hair look thicker or hide hair loss.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Dermoscopy is useful for diagnosing different types of hair loss.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Scalp cooling effectively reduces hair loss from chemotherapy.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.